DARK SECRETS: Macular degeneration | Rare Historical Photos

GLP-1 Users with Type 2 Diabetes Had 31% Lower Odds of Macular Degeneration Once Health Factors Were Counted

In a 300-million-patient records study, GLP-1 drugs were linked to 31% lower odds of macular degeneration in type 2 diabetes. Here's what that means.

Medical Daily · Oct 8

An AI Drug Company Named a Candidate for Dry Macular Degeneration, and the Target Is Undisclosed

Insilico Medicine nominated ISM9077 for dry AMD and other eye diseases. What a preclinical candidate designation means and what remains undisclosed.

Medical Daily · Aug 7

FDA Approves the First Eye-Specific Bevacizumab for Wet Macular Degeneration After Two Decades of Off-Label Use

FDA approved Lytenava, the first ophthalmic bevacizumab for wet AMD. What it changes for patients who already get compounded Avastin.

Medical Daily · Aug 3

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10

SHENZHEN, China, June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd. ("Shenzhen Kexing"), a wholly-owned subsidiary of Kexing Biopharm. Designed to treat neovascular…

AAP · Jun 4

EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP-1901, beginning in August, with a second pivotal trial expected to follow about two months later.

MarketBeat · May 26

How looking through static can help people with a common degenerative disease see better

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness among ageing people globally. Around one in seven Australians over the age of 50 have some signs of AMD.

The Conversation · May 17

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m

MarketBeat · May 17

Simple Fatty Acid Injection Reverses Age-Related Vision Loss in Mice and May Help Prevent Macular Degeneration

Discover how experimental fatty acid therapy targeting retinal lipids may help preserve vision and lower macular degeneration risk, based on new age-related eye research in mice.

Medical Daily · Apr 23

AREDS2 Eye Vitamins and Lifestyle Changes for Macular Degeneration Prevention and AMD Prevention

Learn how AREDS2 supplements and lifestyle habits support Macular Degeneration Prevention, AMD prevention, retinal health, and protection against central vision loss with clear, research-informed guidance.

Medical Daily · Apr 4

5 Canned Goods Now Being Linked To Vision Loss

Canned foods are a pantry staple—affordable, convenient, and long-lasting. But recent studies are raising red flags about how some of these items may be quietly harming your eyesight. Experts are now linking certain canned goods to increased risks of vision problems, including age-related macular degeneration (AMD) and cataracts. The culprits?…

Grocery Coupon Guide · Jan 24